Home
Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics, ... Market Share Analysis for May 2026

Supporting DF6002, its Extended Half-life IL-12 Cytokine, as a Promising Treatment for CancerThe publication titled "An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses" was published on April 13th in Cell Press's Med.WALTHAM, Mass., April 17, 2023 /PRNewswire/ -- Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced the April 13th publication of preclinical d

Health > Biotechnology and Pharmaceuticals

Domaindragonflytx.com

Year Founded2015

Employees51 - 200

Annual Revenue$5M - $10M

Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics, Inc. (including company regionals)

dragonflytx.com

See more website traffic and engagement information

Dragonfly Therapeutics, Inc. Revenue up to May 2026 is 5M - 10M

revenue generated by Dragonfly Therapeutics, Inc. top domains

Dragonfly Therapeutics, Inc. top domains revenue over 3 years

Revenue for Dragonfly Therapeutics, Inc. top domains

dragonflytx.com5M - 10M

See more with Sales Intelligence

Total visits to Dragonfly Therapeutics, Inc.'s top domains

Understand Dragonfly Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

dragonflytx.com4.4K

See more with Sales Intelligence

Avg. visit duration in Dragonfly Therapeutics, Inc.'s top domains

Analyze Dragonfly Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

dragonflytx.com00:00:19

See more with Sales Intelligence

Avg. pageviews on Dragonfly Therapeutics, Inc.'s top domains

See how Dragonfly Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

dragonflytx.com1.87

See more with Sales Intelligence

Dragonfly Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Dragonfly Therapeutics, Inc.

These are the website technologies, by industry, used by Dragonfly Therapeutics, Inc. top domains

Advertising (5)

DoubleClick

Mobile (3)

Meta Viewport

Payment & Currencies (3)

Cart Functionality

Audio Video Media (2)

MPEG-DASH

More Technologies

8

See all

News & Signals from Dragonfly Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDragonflytx attended event Society for Immunotherapy of Cancer (SITC) Annual Conference on Nov 7th '24.BOSTON, Nov. 7, 2024 /PRNewswire/ - Dragonfly Therapeutics, Inc., a clinical-stage biotechnology company developing novel immunotherapies, today announced the company will deliver poster presentations at the Society for Immunotherapy of Cancer (SITC) Annual Conference, highlighting preclinical data supporting two clinical-stage assets, DF6215, its engineered IL-2 cytokine, and DF9001, its EGFR-targeting TriNKET, for the treatment of advanced solid tumors.

NewsDragonflytx hires Susan as co-founder and CEO."We are delighted that Susan has joined Dragonfly," said Bill Haney, co-founder and CEO of Dragonfly Therapeutics.